Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Autoimmunity has long been linked to myocarditis and its sequela, dilated cardiomyopathy, the leading causes of heart failure in young patients. However, the underlying mechanisms are poorly defined, with most clinical investigations focused on humoral autoimmunity as the target for intervention. Here, we show that the α-isoform of myosin heavy chain (α-MyHC, which is encoded by the gene Myh6) is the pathogenic autoantigen for CD4+ T cells in a spontaneous mouse model of myocarditis. Further, we found that Myh6 transcripts were absent in mouse medullary thymic epithelial cells (mTECs) and peripheral lymphoid stromal cells, which have been implicated in mediating central and peripheral T cell tolerance, respectively. Transgenic expression of α-MyHC in thymic epithelium conferred tolerance to cardiac myosin and prevented myocarditis, demonstrating that α-MyHC is a primary autoantigen in this disease process. Remarkably, we found that humans also lacked α-MyHC in mTECs and had high frequencies of α-MyHC-specific T cells in peripheral blood, with markedly augmented T cell responses to α-MyHC in patients with myocarditis. Since α-MyHC constitutes a small fraction of MyHC in human heart, these findings challenge the longstanding notion that autoimmune targeting of MyHC is due to its cardiac abundance and instead suggest that it is targeted as a result of impaired T cell tolerance mechanisms. These results thus support a role for T cell-specific therapies for myocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Animal models of myocarditis have yielded a wealth of information about the pathogenesis of disease including a number of landmark articles that demonstrate that myocarditis is an autoimmune disease that requires TLR activation by microbes. 44,152,153”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [153]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that α -MyHC is expressed in both the atrium and ventricle of mouse hearts”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies on autoreactive cardiac myosin-specific T cells indicated that they escape negative selection in the thymus and can be found in circulation as well as in naive hearts, marked by CD69 expression, a well-known marker for tissue residency in T cells. 42,47”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“autoreactive T cells that recognize α -MyHC naturally develop in every individual”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“T cells specific for α -MyHC were identified as self-antigen-recognizing T-cell clones that escape thymic negative selection, migrate to the heart, and trigger autoimmune myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
Lipshultz, S. E., Sleeper, L. A., Towbin, J. A., Lowe, A. M., Orav, E. J., Cox, G. F., Lurie, P. R., McCoy, K. L., McDonald, M. A., Messere, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021715 · Cited by 890
Mann, D. L., Zipes, D. P., Libby, P., Bonow, R. O., & D, E. B. M. (2015) · Elsevier eBooks · Cited by 882
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809
The Epidemiology of Childhood Cardiomyopathy in Australia
Nugent, A. W., Daubeney, P. E. F., Chondros, P., Carlin, J. B., Cheung, M., Wilkinson, L. C., Davis, A. M., Kahler, S. G., Chow, C. W., Wilkinson, J. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021737 · Cited by 785
A CENTRAL ROLE FOR CENTRAL TOLERANCE
Kyewski, B., & Klein, L. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115601 · Cited by 748
Self-citationFrustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604
Cited by
Items 101–200 of 232
Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy
Tajiri, K., Yonebayashi, S., Li, S., & Ieda, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624703 · Cited by 23
“In addition topresenting antigen-derived peptides on their MHCs with costimulatory molecules for naïve T cell activation and expansion, DCs release a cocktail of polarizing cytokines for the differentiation of CD4 T cells into effector cells (30, 62).”
BackgroundInfluentialGalectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice
Kovačević, M. M., Pejnovic, N. N., Mitrović, S., Jovicic, N. U., Petrović, I., Arsenijević, N., Lukić, M. L., & Ljujić, B. (2018) · Immunologic Research · doi:10.1007/s12026-018-9013-8 · Cited by 23
Thelemann, C., Haller, S., Błyszczuk, P., Kania, G., Rosa, M., Eriksson, U., Rotman, S., Reith, W., & Acha‐Orbea, H. (2015) · European Journal of Immunology · doi:10.1002/eji.201545945 · Cited by 22
Spiliopoulou, P., van Rensburg, H. J. J., Avery, L. M., Kulasingam, V., Razak, A. R. A., Bedard, P. L., Hansen, A. R., Chruscinski, A. J., Wang, B., Kulikova, M., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-022-05548-4 · Cited by 23
“MYH6 has previously been shown to function as an autoantigen in myocarditis [49], and autoantibodies against MYH6 have been observed in patients hospitalized with COVID-19 [50].”
BackgroundLymphocytes at the Heart of Wound Healing
Silva, V. M. D. S., Frantz, S., & Ramos, G. C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_11 · Cited by 23
Sousa, G. R., Kosiborod, M., Bluemke, D. A., & Lipes, M. A. (2020) · Circulation · doi:10.1161/circulationaha.119.044539 · Cited by 20
Self-citationThe knowns and unknowns of cardiac autoimmunity in viral myocarditis
Mone, K., & Reddy, J. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2478 · Cited by 19
“While exogenously acquired, phagosome ‐ originated microbial antigens are presented to CD4 T cells in the contextofMajorHistocompatibilityComplex(MHC)classIImolecules; cytoplasmic proteins, importantly viral antigens generated endogenously, are presented to CD8 T cells through the class I pathway.”
Myocardial-Treg Crosstalk: How to Tame a Wolf
Weiß, E., Ramos, G. C., & Delgobo, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914033 · Cited by 20
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular Therapies
Hume, R. D., & Chong, J. J. H. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.09.006 · Cited by 20
Martín, P., Blanco-Domínguez, R., & Sánchez‐Díaz, R. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00586-4 · Cited by 18
“As discussed above, some T cell clones that recognize cardiac epitopes escape negative selection in the thymus, so when peripheral tolerance mechanisms are blocked by immunotherapy, the expansion of a heart-specific T cell response can be triggered.(151) Although CD69 involvement in human disease remains unexplored, p…”
BackgroundWang, Y., Singh, K., Lokman, A. B., Deng, S., Sunitha, B., Lima, J. C., Jr., Beglov, J., Kelly, M., Blease, A., Fung, J. C. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3516 · Cited by 19
Wang, T., Wang, S., Jia, X., Li, C.-L. F., Ma, X., Tong, H., Liu, M., & Li, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155558 · Cited by 19
Autoimmune-Like Mechanism in Heart Failure Enables Preventive Vaccine Therapy
Martini, E., Cremonesi, M., Felicetta, A., Serio, S., Puccio, S., Pelamatti, E., van Beek, J. J. P., Papadopoulou, V., Catalano, C., Fanuele, F., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324999 · Cited by 18
Lipes, M. A., & Galderisi, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0598-1 · Cited by 19
Self-citationSattler, S., Couch, L. S., & Harding, S. E. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.11.003 · Cited by 18
Exploring T Cell Receptor Repertoires in Myocardial Diseases
Ashour, D., Gouge, K. L., Rainer, P. P., Mariotti‐Ferrandiz, E., & Ramos, G. C. (2024) · Circulation Research · doi:10.1161/circresaha.124.323661 · Cited by 18
“100,138–145 Thus, a more in-depth characterization of BCR/immunoglobulin repertoires and network analyses in myocardial diseases is needed and posed to have a significant impact in the field.”
Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases
Naya, N. M., Kelly, J., Hogwood, A. C., Abbate, A., & Toldo, S. A. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2351513 · Cited by 22
“In this sense, the α-isoform of myosin heavy chain (α-MyHC) is a pathogenic auto-antigen for CD4+ T cells in autoimmune myocarditis [71].”
Basavalingappa, R. H., Massilamany, C., Krishnan, B., Gangaplara, A., Kang, G., Khalilzad-Sharghi, V., Han, Z., Othman, S., Li, Q., Riethoven, J.-J., et al. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.08.005 · Cited by 17
“The presence of such a repertoire of cells has previously shown to be correlated with the lack of expression of autoantigens, like cardiac myosin and proteolipid protein in the thymus.(43,44)”
BackgroundCardiovascular adverse effects of immunotherapy in cancer: insights and implications
Du, H., Wang, J., & Wang, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1601808 · Cited by 22
Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology
He, Y., Yu, H., Dai, S., He, M., Ma, L., Xu, Z., Luo, F., & Wang, L. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.024 · Cited by 19
“In contrast, transgenic mice, expressing Myh6 in mTECs, are protected from myocarditis induction, which indicates impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice.(92,93,103)”
BackgroundThe inflammatory spectrum of cardiomyopathies
Musigk, N., Suwalski, P., Golpour, A., Fairweather, D., Klingel, K., Martín, P., Frustaci, A., Cooper, L. T., Lüscher, T. F., Landmesser, U., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1251780 · Cited by 21
“Lv et al. demonstrated that autoimmunity plays a role in ICI-induced myocarditis by demonstrating that CD4 + T cells speci fi c for alpha myosin heavy chain were not effectively eliminated in the thymus of mice and humans after receiving immune checkpoint inhibitors (244).”
BackgroundAguilar, S. V., Cui, M., Tan, W. H., Sanchez‐Ortiz, E., Bassel‐Duby, R., Liu, N., & Olson, E. N. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00447-7 · Cited by 20
Reaction of food‐specific antibodies with different tissue antigens
Vojdani, A. (2019) · International Journal of Food Science & Technology · doi:10.1111/ijfs.14467 · Cited by 16
“…in cardiovascular autoimmunity, tyrosinase in autoimmune vitiligo, and neurotrophin in MS, alopecia areata and Alzheimer’s disease (Botchkarev, 2003; Ongenae et al., 2003; Lv et al., 2011; Andres & Serraj, 2012; Kalinowska-Lyszczarz & Losy, 2012; Fr€ohlich & Wahl, 2017; Vojdani et al., 2018).”
BackgroundHLA transgenic mice: application in reproducing idiosyncratic drug toxicity
Susukida, T., Aoki, S., Shirayanagi, T., Yamada, Y., Kuwahara, S., & Ito, K. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1800725 · Cited by 16
Kreidieh, F., & McQuade, J. L. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100374 · Cited by 20
“There are a number of mechanisms that have been described, including T cell and B cell-mediated, with increased cardiac-specific antimyosin autoantibodies and cardiac antigen-specific T cells [157 – 159].”
BackgroundLin, H., Lee, D.-C., Wang, H., Chi, Y., & Chiu, I. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0157 · Cited by 16
“…¢ [28]; myosin, heavy polypeptide 6, cardiac muscle, a ( a -MHC)—FW: 5 ¢ -AACCAGAGTTTGA GTGACAGAATG-3 ¢ , RV: 5 ¢ -ACTCCGTGCGGATGTC AA-3 ¢ [29]; Mlc2v—FW: 5 ¢ -ACTTCACCGTGTTCCTCA CGATGT-3 ¢ , RV: 5 ¢ -TCCGTGGGTAATGATGTGGACC AA-3 ¢ [30]; and FGF1A and FGF1B primer sequences were as…”
Geenen, V. G. (2012) · PubMed · doi:10.2143/acb.67.3.2062657 · Cited by 19
How can we manage the cardiac toxicity of immune checkpoint inhibitors?
Poto, R., Marone, G., Pirozzi, F., Galdiero, M. R., Cuomo, A., Formisano, L., Bianco, R., Corte, C. M. D., Morgillo, F., Napolitano, S., et al. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1906860 · Cited by 14
“Also, impaired thymic tolerance to myosin antigens is potential mechanism of development for ICI related cardiovascular irAEs [66], and furthermore Gil-Cruz and colleagues [67] demonstrated that progression of autoimmune myocarditis to lethal heart disease depends on cardiac myosin-specific Th17 cells imprinted in the…”
BackgroundGeenen, V. G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06624.x · Cited by 15
Takotsubo syndrome and rheumatic diseases—a critical systematic review
Lin, W., Tay, S. H., & Mak, A. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa504 · Cited by 13
Implication of microRNA as a potential biomarker of myocarditis
Oh, J.-H., Kim, G. B., & Seok, H. (2022) · Korean Journal of Pediatrics · doi:10.3345/cep.2021.01802 · Cited by 17
Humoral autoimmunity after solid organ transplantation: Germinal ideas may not be natural
Siu, J. H. Y., Motallebzadeh, R., & Pettigrew, G. J. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104131 · Cited by 14
Preclinical mouse models of immune checkpoint inhibitor-associated myocarditis
Fankhauser, R. G., Johnson, D. B., Moslehi, J. J., & Balko, J. M. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00640-2 · Cited by 14
“DQ8 mice 123 .”
InfluentialA humanized HLA-DR4 mouse model for autoimmune myocarditis
Şelli, M. E., Thomas, A. C., Wraith, D. C., & Newby, A. C. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.04.003 · Cited by 12
Shi, M., Tang, R., Huang, F., Zhong, T., Chen, Y., Li, X., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3423 · Cited by 15
Insulin promotes T cell recovery in a murine model of autoimmune myocarditis
Zhang, Y., Zhuang, R., Geng, C., Cai, X., Lei, W., Tian, N., & Gao, F. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04662.x · Cited by 16
Li, J., Chen, L., Liu, X., Zhang, M., & Liu, X. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.09.006 · Cited by 12
Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor‐Associated Myocarditis
Jo, W., Sun, V., & Čiháková, D. (2026) · Immunological Reviews · doi:10.1111/imr.70111 · Cited by 12
Is Ischaemic Heart Failure an Autoimmune Disease?
Sattler, S. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14636 · Cited by 10
Geenen, V. G., Trussart, C., Michaux, H., Halouani, A., Jaïdane, H., Collée, C., Renard, C., Daukandt, M., Ledent, P., & Martens, H. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14089 · Cited by 13
Etiopathogenesis of Insulin Autoimmunity
Kanatsuna, N., Papadopoulos, G. K., Moustakas, A. K., & Lernmark, Å. (2012) · Anatomy Research International · doi:10.1155/2012/457546 · Cited by 14
“The impaired expression of alpha-myosin in the thymus in mice and humans was shown to be intimately linked to autoimmunity in the heart [201].”
BackgroundInsight of immune checkpoint inhibitor related myocarditis
Pi, J.-K., Chen, X.-T., Zhang, Y., Chen, X.-M., Wang, Y.-C., Xu, J., Zhou, J.-H., Yu, S.-S., & Wu, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113559 · Cited by 14
Cellular Immunology of Myocarditis: Lights and Shades—A Literature Review
Vicenzetto, C., Giordani, A. S., Menghi, C., Baritussio, A., Scognamiglio, F., Pontara, E., Bison, E., Cattini, M. G., Marcolongo, R., & Caforio, A. L. P. (2024) · Cells · doi:10.3390/cells13242082 · Cited by 15
“…that in EAM and in humans, medullary thymic epithelial cells, which are critical for central T cell tolerance, lack the expression of α -MyHC, leading to a defective control over α -MyHC autoantigens, allowing the increased presence of α -MyHC- T cells specifically in peripheral blood [99].”
Autoantibodies—epiphenomena or biological clues
Halloran, P. F. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.221 · Cited by 10
Li, S., Tajiri, K., Yuan, Z., Murakata, Y., Song, Z., Mizuno, S., Xu, D., & Murakoshi, N. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01089-3 · Cited by 10
“Upon encountering immunologic danger, the activated DCs act as important commanders regulating CD4 + T cells by means of antigen presentation, costimulatory molecule engagement, and release of a cocktail of polarizing cytokines [12, 19].”
Jin, J., Qin, S., Fu, Q., Yu, C., & Wu, H. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1580880 · Cited by 10
Immune cell dilemma in ischemic cardiomyopathy: to heal or not to heal
Nehra, S., Gumina, R. J., & Bansal, S. S. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.09.002 · Cited by 10
Ciccarelli, M., Falcão‐Pires, I., Bauersachs, J. K., Bertrand, L., Beauloye, C., Dawson, D. K., Hamdani, N., Hilfiker‐Kleiner, D., Laake, L. W. V., Lezoualc’h, F., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad088 · Cited by 11
Sur, M., Rasquinha, M. T., Mone, K., Massilamany, C., Lasrado, N., Gurumurthy, C. B., Sobel, R. A., & Reddy, J. (2024) · Cells · doi:10.3390/cells13030234 · Cited by 11
“Such skewed CD4 to CD8 ratios have been reported in other transgenic models, and asymmetric cell death of CD4 + and CD8 + thymocytes during development may be an underlying mechanism [26,27].”
BackgroundTajiri, K., Imanaka‐Yoshida, K., Tsujimura, Y., Matsuo, K., Hiroe, M., Aonuma, K., Ieda, M., & Yasutomi, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020794 · Cited by 9
“Among several cardiac selfantigens targeted during chronic heart inflammation, cardiac myosin heavy chain α isoform (MyHCα) has been identified as the most prominent autoantigen in myocarditis and DCM [9,10].”
BackgroundAIRE's Complex Role Beyond Promiscuous Gene Expression
Peterson, P. (2025) · Immunological Reviews · doi:10.1111/imr.70091 · Cited by 9
T cells in acute and chronic myocarditis: from diagnosis to treatment
Song, E. J., Joachimbauer, A., Tasca, S., Baylis, R. A., Schmidt, D., Ludewig, B., & Moslehi, J. J. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehaf1080 · Cited by 11
“In contrast, cardiac proteins such as MYH6 are not expressed in the thymus 17–19 facilitating the exit of MYH6-specific T cells from the thymus ( Figure 2B ) 17,20 and their migration to heart-draining lymph nodes.”
InfluentialMyocarditis: a defect in central immune tolerance?
Metzger, T. C., & Anderson, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57211 · Cited by 9
Novel therapeutic options in inflammatory cardiomyopathy
Kania, G., Błyszczuk, P., Müller‐Edenborn, B., & Eriksson, U. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13841 · Cited by 13
Reinsmoen, N. L. (2016) · Transplantation · doi:10.1097/tp.0000000000001495 · Cited by 8
Griffin, G. K., & Lichtman, A. H. (2013) · Circulation · doi:10.1161/circulationaha.113.003261 · Cited by 8
Immune checkpoint inhibitor-associated myocarditis: a review of current state of knowledge
Ostos-Mendoza, K. C., Saraiba-Rabanales, V., Gutierrez‐Gallegos, P., Wang, E., Koutroumpakis, E., Kumar, S., Khalaf, S. Z., Ali, H.-J., Deswal, A. M., & Palaskas, N. L. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.13 · Cited by 10
van der Vegt, S. A., Wang, Y., Polonchuk, L., Wang, K., Waters, S. L., & Baker, R. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.966180 · Cited by 9
“In order for a protein to be recognized as “self” and not elicit an immune response, it must therefore be presented in the thymus (Lv et al., 2011; Bracamonte-Baran and Cihakova, 2017).”
BackgroundInfluentialYoung, N. A., Jablonski, K., Schwarz, E., Okafor, I., Hampton, J. M., Valiente, G. R., Henry, C., Harb, P., Barger, J., Bratasz, A., et al. (2020) · Lupus · doi:10.1177/0961203320948959 · Cited by 9
“Thymic medullary epithelial cells in both mice and humans do not express transcripts of the a-isoform of myosin heavy chain (a-MyHC), which results in autoreactive T cells targeting this antigen.(25,26) Indeed, mouse models have shown that transgenic mice carrying T cell receptors targeting a-MyHC develop myocarditis…”
BackgroundAdvances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis
Shao, J., Liu, C., & Wang, J. (2023) · Cancer Innovation · doi:10.1002/cai2.100 · Cited by 9
“Lv et al. [45] demonstrated that thymic CD4 + T cells lack tolerance to α ‐ MyHC, making them susceptible to this severe disease.”
BackgroundRegulating heart repair with cardiac-specific T lymphocytes
Mallat, Z. (2019) · Journal of Clinical Investigation · doi:10.1172/jci132441 · Cited by 8
“Intriguingly, CD4+ T cells with TCRs specific for some tissue-restricted self-antigens, including cardiac myosin heavy chain α (MYHCA), escape central negative selection (1, 3) and may therefore make the respective tissues vulnerable to autoimmune attack.”
BackgroundStaab, J., Ruppert, V., Pankuweit, S., & Meyer, T. (2012) · Herz · doi:10.1007/s00059-012-3698-6 · Cited by 7
Role of T Cells in Viral and Immune-mediated Myocarditis
Cheng, C., Baritussio, A., Giordani, A. S., Marcolongo, R., Caforio, A. L. P., & Iliceto, S. (2024) · Cardiology Discovery · doi:10.1097/cd9.0000000000000116 · Cited by 6
RNA-ssisting immunity to heal the heart: a new frontier in therapeutics
Rurik, J. G., Phu, C. L., Mustroph, J., & Buggert, M. (2025) · Cardiology Plus · doi:10.1097/cp9.0000000000000116 · Cited by 6
“Interestingly, one of the proposed sarcomere proteins, Myh6, targeted by anti-heart T cells is not expressed by thymus endothelium [29] , suggesting that a pool of circulating precursors exist that are held in-check by peripheral tolerance, which may be overcome by significant myocardial damage,…”
Tong, H., Wang, S., Liu, M., Wang, T., Jia, X., Li, Y., Yu, D., & Li, L. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110029 · Cited by 6
Recurrent Congestive Heart Failure in a Child Due to Probable Myocarditis
Lee, A. F., Chiasson, D. A., Smythe, J., & Sanatani, S. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-0109-3 · Cited by 7
Reinsmoen, N. L. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.06.010 · Cited by 6
Halouani, A., Michaux, H., Jmii, H., Trussart, C., Chahbi, A., Martens, H., Renard, C., Aouni, M., Hober, D., Geenen, V. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9071537 · Cited by 6
“[53], who reported the absence of Myo6 expression in the whole thymus and purified thymic cell subsets from B6, NOD, and DQ8+NOD mice.”
BackgroundLi, Q., Hu, W., Liao, B., Song, C., & Li, L. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004713 · Cited by 8
“39”
CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion
Noonan, J. E., Prijaya, S. A., Bienvenu, L. A., Dayawansa, N. H., Michla, M., Bongcaron, V., Sharma, P., Song, Y., Huang, A., Barbaro-Wahl, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf165 · Cited by 8
“Current data demonstrate that heart-specific autoreactive T cells can escape from the thymus 50,51 with the ability to differentiate into pro-inflammatory phenotypes and breach immunological tolerance.”
Chen, Y., Wang, X., Shen, Y., Zhang, H., Yu, C., Cheng, L., & Ge, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.12.004 · Cited by 5
Chronic Active Myocarditis and Inflammatory Cardiomyopathy ― Challenges in Diagnosis and Treatment ―
Nagai, T., Katsuki, M., Amemiya, K., Takahashi, A., Oyama‐Manabe, N., Ohta‐Ogo, K., Imanaka-Yoshida, K., Ishibashi-Ueda, H., & Anzai, T. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0246 · Cited by 9
Huang, Y., Huang, X., Wei, Z., Dong, J., Lu, J., Tang, Q., Lu, F., Cen, Z., & Wu, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111304 · Cited by 6
Immune Cell Dynamics in Heart Failure: Implicated Mechanisms and Therapeutic Targets
Li, G., He, W., & Wang, D. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15238 · Cited by 8
BMP4 mediates myocardial inflammation and fibrosis
Martín, P. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00452-w · Cited by 3
Intracellular Cardiac Signaling Pathways Altered by Cancer Therapies
Scott, S. S., Greenlee, A. N., Schwendeman, E. J., Mohammad, S. J., Naughton, M. T., Matzko, A., Diallo, M., Stein, M., Revan, R., Zaramo, T. Z., et al. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_4 · Cited by 6
Unchecked autoreactive CD8+ T cells wreak havoc in cancer immunotherapy
Wong, A., & Epelman, S. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00184-9 · Cited by 4
Pathogenic drivers of lupus myocarditis and potential therapeutic targets
Liu, Y., Murphy, K. M., Hung, Y. F., & Won, T. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01580-4 · Cited by 4
“The presence and pathogenicity of MyHC-speci fi c autoreactive T cells have been studied in various in fl ammatory cardiac conditions, including viral myocarditis, autoimmune myocarditis, ICI-associated myocarditis and dilated cardiomyopathy 15,17,77 .”
InfluentialT Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases
Richter, L., Dias-Ferreira, J., Ramos, G. C., & Ashour, D. (2026) · Immunological Reviews · doi:10.1111/imr.70125 · Cited by 5
Myocardial Immune Niches in Homeostasis and Inflammation
Perez‐Shibayama, C., Cadosch, N., Schmidt, D., Flammer, A. J., Ruschitzka, F. T., Gil‐Cruz, C., & Ludewig, B. (2026) · Immunological Reviews · doi:10.1111/imr.70139 · Cited by 4
“For example, MYH6-specific T cells escape thymic negative selection due to the absence of this protein in medullary thymic epithelial cells, thereby establishing a peripheral pool of potentially cardiopathogenic T cells in mice and humans [139–141].”
Sex differences in coronavirus disease 2019 myocarditis
Beetler, D. J., & Fairweather, D. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100704 · Cited by 3
Background and roles: myosin in autoimmune diseases
Fu, L., Zou, Y., Yu, B., Hong, D., Guan, T., Hu, J., Xu, Y., Wu, Y., Kou, J., & Lv, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1220672 · Cited by 4
“For example: MYH6 is suggested to be targeted on CD4 T cell in a spontaneous mouse model of myocarditis (Lv et al., 2011).”
BackgroundImmune heterogeneity in cardiovascular diseases from a single-cell perspective
Su, X., Wang, L., Ma, N., Yang, X., Liu, C., Yang, F., Li, J., Yi, X., & Xing, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1057870 · Cited by 5
“The α -myosin heavy chain is a pathogenic autoantigen in a mouse model of spontaneous myocarditis, allowing CD4 + T cells to speci fi cally evade thymic negative selection and spread to the periphery (71).”
Thymus as Incontrovertible Target of Future Immune Modulatory Therapeutics
Khan, G. J., Imtiaz, A., Wang, W., Duan, H. Q., Cao, H., Zhai, K., & He, N. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303283164240126104109 · Cited by 4
Jensen, G. L., Wang, X., Kuempel, J., Chen, Z., Yu, W., Palaskas, N. L., Sobieski, M. M., Nguyen, N. C., Powell, R. T., STEPHAN, C. C., et al. (2024) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2024.100122 · Cited by 5
Organ-Specific Autoimmune Myocardial Diseases
Caforio, A. L. P., Marcolongo, R., Malipiero, G., Agostini, C., Seguso, M., Gallo, N., Plebani, M., & Iliceto, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00002-8 · Cited by 3
Tissue‐Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation
Manandhar, P., Yan, A., & Moslehi, J. J. (2026) · Immunological Reviews · doi:10.1111/imr.70134 · Cited by 3
“T cells specific for α-myosin heavy chain (α-MyHC) have emerged as the dominant antigen target in both mice and humans, as α-MyHC is not expressed in the thymus and escapes negative selection [9].”
CD8+ T cells as the missing link between doxorubicin cancer therapy and heart failure risk
Sattler, S., & Ljubojević-Holzer, S. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00513-0 · Cited by 2
Jin, Y., Xu, S., Liu, X., Zhang, Q., Li, X., Zhang, H., Ma, J., Leng, L., & Zhang, S. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03791-4 · Cited by 3
“More-over, CD4 + T cell responses, specifically, have the capacity to transform an initial myocarditis condition into an autoimmune reaction [8, 9].”
BackgroundTajiri, K., 郁夫, 関., & 真樹, 家. (2019) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.28.0_3 · Cited by 2
Lv, H., Raddassi, K., & Lipes, M. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8938-6_14 · Cited by 2
Self-citationIdentification of a novel myosin antigen activating CD8 + T cells in C57BL/6 micePreprint
Richter, L., Bauer, M., Bernsen, C., Vogel, E., Mahmud, Z., Saliba, A., Schulz, R., Frantz, S., Ashour, D., & Ramos, G. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.26.605251 · Cited by 4
“34-36 Given that multiple studies highlighted the importance of MYHCA epitopes to immune responses in cardiac pathologies, 4,8,10-18 it is plausible to assume that MYHCA 724-732 -reactive T cells might also be physiologically relevant.”
BackgroundJoachimbauer, A., Perez-Shibayama, C., Payne, E., Hanka, I., Stadler, R., Papadopoulou, I., Rickli, H., Mäder, M. T., Borst, O., Zdanyte, M., et al. (2026) · medRxiv · doi:10.64898/2026.04.10.26350598 · Cited by 1
Bruns, F., Fender, A. C., Poppenborg, T., Dudley, S. C., & Dobrev, D. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf252 · Cited by 2
Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions
Abdalla, H. M., Bacon, A., VanDolah, H. B., Dreher, L. A., Pathangey, G., Abdelnabi, M. H., Ramzi, I., Pereyra, M., Farina, J., Luis, S. A., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.10.009 · Cited by 4
Lu, T., Song, X., Zhang, T., & Ge, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1810121 · Cited by 2
“Insufficient or aberrant expression of certain self-antigens, such as cardiac myosin heavy chain alpha (MYHCA), allows autoreactive T cells to evade negative selection, thereby escaping thymic deletion (Lv et al., 2011).”
Dendritic Cells in Inflammatory Disease
Lambrecht, B. N., Guilliams, M., & Hammad, H. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch12 · Cited by 1
Rola autoimmunizacji w rozwoju powikłań cukrzycowych – przegląd badań
Łukawska-Tatarczuk, M. M., Mrozikiewicz‐Rakowska, B., Franek, E., & Czupryniak, L. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0043 · Cited by 2
Fibroblasts tune myocardial inflammation and remodeling
Perez‐Shibayama, C., Gil‐Cruz, C., & Ludewig, B. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00119-4 · Cited by 1
Hamann, C. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5789 · Cited by 1
Metadata
- Authors
- Lv, H., Havari, E., Pinto, S., Gottumukkala, R. V. S. R. K., Cornivelli, L., Raddassi, K., Matsui, T., Rosenzweig, A., Bronson, R. T., Smith, R., Fletcher, A. L., Turley, S. J., Wucherpfennig, K., Kyewski, B., & Lipes, M. A.
- Affiliations
- Joslin Diabetes Center (US)
- Harvard University (US)
- German Cancer Research Center (DE)
- Corresponding author
- Lipes, Myra A.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1561-1573
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069776
- OpenAlex
- W2102807926
- Semantic Scholar
- 390386d1ea9c282aa38a38b3f6bfa36ad69df7d0
- Cited by
- 228
- References
- 71
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 31 · 2023: 19 · 2022: 17 · 2021: 13 · 2020: 15 · 2019: 17 · 2018: 10 · 2017: 12 · 2016: 6 · 2015: 9 · 2014: 7 · 2013: 12 · 2012: 13
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Joslin Diabetes Center
- Deutsches Krebsforschungszentrum
- European Commission
- Deutsche Forschungsgemeinschaft (SFB405)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL077554, R01HL077554)
- National Institute of Allergy and Infectious Diseases (P01AI045757)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK074500, DK074500, R01DK072090)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myocarditis, dilated cardiomyopathy, autoimmunity, MYH6, thymic tolerance, medullary thymic epithelial cells, CD4+ T cells, autoantigens, T cell tolerance, transgenic mice, heart failure
- MeSH terms
- Animals, Autoantigens, Base Sequence, Disease Models, Animal, Female, HLA-DQ Antigens, Humans, Immune Tolerance, Infant, Infant, Newborn, Male, Mice, Inbred C57BL, Mice, Transgenic, Myocarditis, Myocardium, Thymus Gland, CD4-Positive T-Lymphocytes, Autoimmunity, Mice, Inbred NOD, DNA Primers, Mice, Knockout, Myosin Heavy Chains, Cardiac Myosins, Ventricular Myosins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.